Tech Company Financing Transactions
HTG Molecular Diagnostics Funding Round
On 2/24/2011, HTG Molecular Diagnostics received $15.7 million in Series D funding from Novo Ventures, Fletcher Spaght Ventures and Merck Capital Ventures.
Transaction Overview
Novo Ventures (Lead Investor) (Peter Bisgaard)
Fletcher Spaght Ventures (Molly Hoult)
Solstice Capital (Harry George)
Company Information
Tucson, AZ 85706
USA
Management Team
Browse more venture capital transactions:
Prev: 2/24/2011: textPlus venture capital transaction
Next: 2/24/2011: Box venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs